Thyrotoxic patient with nodule is treated with:
**Core Concept**
The management of a thyrotoxic patient with a nodule involves addressing both the hyperthyroidism and the nodule itself. This requires a thorough understanding of the pathophysiology of thyroid disease, including the role of thyroid-stimulating hormone (TSH) and thyroid hormone production.
**Why the Correct Answer is Right**
In a patient with a thyrotoxic nodule, the goal is to reduce thyroid hormone production and shrink the nodule. Radioiodine therapy is a commonly used treatment that involves administering radioactive iodine, which selectively destroys thyroid tissue and reduces thyroid hormone production. This approach is particularly useful in patients with a solitary nodule, as it can help reduce symptoms and shrink the nodule over time.
**Why Each Wrong Option is Incorrect**
**Option A:** Surgery is typically reserved for patients with a large nodule causing compressive symptoms or those who are unable to tolerate medical therapy. While surgery can be effective, it is not the first line of treatment for a thyrotoxic patient with a nodule.
**Option B:** Methimazole is a medication used to treat hyperthyroidism by inhibiting thyroid hormone production. However, it is not effective in shrinking thyroid nodules and may not be sufficient as a standalone treatment for a thyrotoxic patient with a nodule.
**Option C:** Beta blockers, such as propranolol, are used to manage the symptoms of hyperthyroidism, including tremors and palpitations. However, they do not address the underlying cause of the thyrotoxicosis or the nodule itself.
**Clinical Pearl / High-Yield Fact**
Radioiodine therapy is most effective in patients with a solitary nodule, as it can selectively destroy thyroid tissue without affecting surrounding tissues. However, it is essential to ensure that patients are euthyroid before administering radioactive iodine to avoid exacerbating symptoms.
**Correct Answer:** D. Radioiodine therapy.